The current financial score of Surgery Partners Inc is 8.32. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 848.90M, representing a year-over-year increase of 2.75%, while its net profit experienced a year-over-year increase of 500.00%.
The current valuation score of Surgery Partners Inc is 8.32. Its current P/E ratio is -39.04, which is -13078.31% below the recent high of 5066.67 and -848.20% above the recent low of -370.17.
The current earnings forecast score of Surgery Partners Inc is 8.00. The average price target is 22.17, with a high of 23.50 and a low of 19.00.
The current price momentum score of Surgery Partners Inc is 6.28. Currently, the stock price is trading between the resistance level at 26.49 and the support level at 16.80, making it suitable for range-bound swing trading.
The current institutional shareholding score of Surgery Partners Inc is 10.00. The latest institutional shareholding proportion is 128.82%, representing a quarter-over-quarter increase of 5.74%.
The current risk assessment score of Surgery Partners Inc is 3.77. The company's beta value is 1.98. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.